PUBMED FOR HANDHELDS

Journal Abstract Search


154 related items for PubMed ID: 11095445

  • 1. Cerebrospinal fluid corticotropin-releasing hormone in healthy humans: effects of yohimbine and naloxone.
    Vythilingam M, Anderson GM, Owens MJ, Halaszynski TM, Bremner JD, Carpenter LL, Heninger GR, Nemeroff CB, Charney DS.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4138-45. PubMed ID: 11095445
    [Abstract] [Full Text] [Related]

  • 2. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF, Bao AM, Lucassen PJ.
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [Abstract] [Full Text] [Related]

  • 3. The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion.
    Torpy DJ, Grice JE, Hockings GI, Crosbie GV, Walters MM, Jackson RV.
    J Clin Endocrinol Metab; 1995 Mar; 80(3):802-6. PubMed ID: 7883833
    [Abstract] [Full Text] [Related]

  • 4. Effects of trauma-related audiovisual stimulation on cerebrospinal fluid norepinephrine and corticotropin-releasing hormone concentrations in post-traumatic stress disorder.
    Geracioti TD, Baker DG, Kasckow JW, Strawn JR, Jeffrey Mulchahey J, Dashevsky BA, Horn PS, Ekhator NN.
    Psychoneuroendocrinology; 2008 May; 33(4):416-24. PubMed ID: 18295412
    [Abstract] [Full Text] [Related]

  • 5. alpha2-adrenoceptor regulation of the hypothalamic-pituitary-adrenocortical axis in obesity.
    Pasquali R, Vicennati V, Calzoni F, Gnudi U, Gambineri A, Ceroni L, Cortelli P, Menozzi R, Sinisi R, Rio GD.
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):413-21. PubMed ID: 10762283
    [Abstract] [Full Text] [Related]

  • 6. Diurnal variation of cerebrospinal fluid immunoreactive corticotropin-releasing hormone levels in healthy volunteers.
    Kling MA, DeBellis MD, O'Rourke DK, Listwak SJ, Geracioti TD, McCutcheon IE, Kalogeras KT, Oldfield EH, Gold PW.
    J Clin Endocrinol Metab; 1994 Jul; 79(1):233-9. PubMed ID: 8027234
    [Abstract] [Full Text] [Related]

  • 7. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE, Scaccianoce S, Burrello N, Nicolai R, Muscolo LA, Kling MA, Angelucci L, D'Agata R.
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [Abstract] [Full Text] [Related]

  • 8. Concentrations of corticotropin-releasing hormone, norepinephrine, MHPG, 5-hydroxyindoleacetic acid, and tryptophan in the cerebrospinal fluid of alcoholic patients: serial sampling studies.
    Geracioti TD, Loosen PT, Ebert MH, Ekhator NN, Burns D, Nicholson WE, Orth DN.
    Neuroendocrinology; 1994 Dec; 60(6):635-42. PubMed ID: 7535389
    [Abstract] [Full Text] [Related]

  • 9. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI, Ferries LM, Roberts B, Qualls CR, Veldhuis JD, Lisansky EJ.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [Abstract] [Full Text] [Related]

  • 10. Systemic Interleukin-1beta stimulates the simultaneous release of norepinephrine in the paraventricular nucleus and the median eminence.
    MohanKumar SM, MohanKumar PS.
    Brain Res Bull; 2005 May 15; 65(5):451-6. PubMed ID: 15833600
    [Abstract] [Full Text] [Related]

  • 11. Colocalization of corticotropin-releasing hormone and oestrogen receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders.
    Bao AM, Hestiantoro A, Van Someren EJ, Swaab DF, Zhou JN.
    Brain; 2005 Jun 15; 128(Pt 6):1301-13. PubMed ID: 15705605
    [Abstract] [Full Text] [Related]

  • 12. Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans.
    Geracioti TD, Orth DN, Ekhator NN, Blumenkopf B, Loosen PT.
    J Clin Endocrinol Metab; 1992 Jun 15; 74(6):1325-30. PubMed ID: 1317385
    [Abstract] [Full Text] [Related]

  • 13. The stress system in depression and neurodegeneration: focus on the human hypothalamus.
    Bao AM, Meynen G, Swaab DF.
    Brain Res Rev; 2008 Mar 15; 57(2):531-53. PubMed ID: 17524488
    [Abstract] [Full Text] [Related]

  • 14. Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man.
    Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
    J Clin Endocrinol Metab; 1993 Feb 15; 76(2):388-91. PubMed ID: 8381800
    [Abstract] [Full Text] [Related]

  • 15. The effect of naloxone administration on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin in unperturbed horses.
    Alexander SL, Irvine CH.
    Endocrinology; 1995 Nov 15; 136(11):5139-47. PubMed ID: 7588252
    [Abstract] [Full Text] [Related]

  • 16. Elevated basal adrenocorticotropin and evidence for increased central opioid tone in highly trained male athletes.
    Inder WJ, Hellemans J, Ellis MJ, Evans MJ, Livesey JH, Donald RA.
    J Clin Endocrinol Metab; 1995 Jan 15; 80(1):244-8. PubMed ID: 7829620
    [Abstract] [Full Text] [Related]

  • 17. Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia.
    Torpy DJ, Papanicolaou DA, Lotsikas AJ, Wilder RL, Chrousos GP, Pillemer SR.
    Arthritis Rheum; 2000 Apr 15; 43(4):872-80. PubMed ID: 10765933
    [Abstract] [Full Text] [Related]

  • 18. Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: implication of alpha(1)- and alpha(2)-adrenoceptors.
    Laorden ML, Fuertes G, González-Cuello A, Milanés MV.
    J Pharmacol Exp Ther; 2000 May 15; 293(2):578-84. PubMed ID: 10773031
    [Abstract] [Full Text] [Related]

  • 19. Central administration of cocaine- and amphetamine-regulated transcript increases phosphorylation of cAMP response element binding protein in corticotropin-releasing hormone-producing neurons but not in prothyrotropin-releasing hormone-producing neurons in the hypothalamic paraventricular nucleus.
    Sarkar S, Wittmann G, Fekete C, Lechan RM.
    Brain Res; 2004 Mar 05; 999(2):181-92. PubMed ID: 14759497
    [Abstract] [Full Text] [Related]

  • 20. Reduced hypothalamo-pituitary-adrenal axis stress responses in late pregnancy: central opioid inhibition and noradrenergic mechanisms.
    Russell JA, Douglas AJ, Brunton PJ.
    Ann N Y Acad Sci; 2008 Dec 05; 1148():428-38. PubMed ID: 19120138
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.